Japan Contact Lenses Market was valued at $1,065.40 Mn in 2023 and is predicted to grow at a CAGR of 9.4% from 2023 to 2030, to $1,998.18 Mn by 2030. The key drivers of this industry include rising disposable income, high prevalence of myopia, and focus on appearance and active lifestyles. The industry is primarily dominated by Bausch and Lomb, CooperVision, Alcon Vision, and Essilor among others.
Japan Contact Lenses Market was valued at $1,065.40 Mn in 2023 and is predicted to grow at a CAGR of 9.4% from 2023 to 2030, to $1,998.18 Mn by 2030.
Contact lenses are versatile medical devices placed directly on the eye, serving both functional and cosmetic purposes. They come in several types: soft lenses, made of flexible plastic allowing oxygen to the cornea; rigid gas permeable lenses for sharper vision; hybrid lenses combining features of both; and scleral lenses covering the cornea and sclera, useful for irregular corneas. They correct refractive errors like myopia and hyperopia and cater to cosmetic needs with colored variants. Fitting by an optometrist or ophthalmologist ensures proper selection based on individual eye health and lifestyle. Regular cleaning and adherence to wearing schedules are crucial for preventing infections and maintaining eye health. Risks include infections, dry eyes, and corneal abrasions if not used correctly. Regulated as medical devices, advancements like silicone hydrogel materials and UV-blocking capabilities enhance safety and comfort, making contact lenses a popular choice for vision correction and aesthetic enhancement globally.
In Japan, glaucoma affects approximately 5% of the adult population and stands as the leading cause of blindness and visual impairment. Dry Eye Disease (DED) is also prevalent, with clinically diagnosed cases reported at 10.1% in men and 21.5% in women, accompanied by severe symptoms in a significant proportion of affected individuals. Among Japanese high school students, DED prevalence ranges from 10% to 20%. Refractive errors are widespread, with myopia impacting between 41% and 60% of adults, while hyperopia and astigmatism affect around 10% to 20% of the population. These conditions collectively highlight significant eye health challenges across different age groups in Japan.
The market therefore is driven by significant factors like the rising prevalence of myopia, increasing disposable income, growing preference for convenience, and technological advancements. However, limited public insurance coverage, lack of awareness regarding proper care, and high costs restrict the growth and potential of the market.
Prominent players in this field are Bausch and Lomb, which emphasizes daily disposable contact lenses enhanced with comfort technologies and supports sustainability initiatives. On the other hand, CooperVision focuses on innovation through advanced materials, specialized solutions for myopia management, and convenient subscription services for contact lenses. Other contributors include Alcon Vision LLC, and Essilor International S.A. among others.
Market Growth Drivers
High Prevalence of Myopia: Statistics from Japan's National Institute of Public Health (NIOPH) suggest a significant portion of the Japanese population experiences myopia (near-sightedness). A 2021 survey revealed that around 80% of Japanese adults aged 18-79 years old need some form of vision correction. This large user base fuels market growth.
Growing Demand for Daily Disposables: Daily disposable lenses are gaining popularity in Japan due to their convenience and reduced risk of infections compared to reusable lenses. Market research indicates that daily disposables account for a growing share of the market, reaching an estimated 40-50% by 2027.
Technological Advancements: Japanese manufacturers are at the forefront of contact lens technology. The introduction of new materials like high-Dk silicone hydrogel and innovative features like multifocality caters to diverse user needs and attracts new customers.
Rising Disposable Income: Japan boasts a developed economy with a stable population. The World Bank estimates Japan's GDP per capita at $41,320 in 2023. This allows people to spend more on discretionary items like contact lenses.
Market Restraints
Eye Care Costs: While the cost of contact lenses themselves is a factor, additional expenses associated with eye examinations, fittings, and solution can add up. This can create a financial burden for some users.
Limited Public Insurance Coverage: Similar to other developed countries, public health insurance in Japan generally doesn't cover the cost of contact lenses for routine vision correction. This can be a barrier for some consumers, particularly those with limited financial resources.
Lack of Awareness Regarding Proper Care: There might be a gap in knowledge regarding proper contact lens hygiene and care practices. This could lead to complications and reduced wear time, potentially discouraging potential users.
In Japan, the regulatory oversight of contact lenses is managed by the Ministry of Health, Labour, and Welfare (MHLW) through the Pharmaceutical and Medical Devices Agency (PMDA). Contact lenses, whether corrective or cosmetic, must undergo rigorous registration with PMDA, ensuring compliance with Japanese medical device regulations. These classifications, primarily Class II and III based on risk, dictate the thoroughness of the registration process, emphasizing safety and performance standards upheld through Quality Management Systems (QMS) adhering to international norms like ISO 13485. Post-market surveillance is mandatory, with manufacturers obligated to monitor lens performance and promptly report any adverse events to PMDA.
Regarding reimbursement, Japan's public health insurance system typically does not cover contact lenses for routine vision correction. Exceptions exist for medically necessary lenses prescribed by an ophthalmologist for conditions like severe myopia or specific eye diseases such as keratoconus. However, coverage is often partial and contingent on the specific insurance plan and individual circumstances. Full reimbursement is rare, underscoring the need for individuals to consult their insurance providers for detailed coverage information based on medical necessity.
Competitive Landscape
Key Players
Here are some of the major key players in the Japan Contact Lenses Market
1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Material
By Design
By Application
By Distribution Channel
By Usage
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.